Detection of plasmid-mediated class C β-lactamases

Yohei Doi, David L. Paterson

Research output: Contribution to journalReview article

67 Citations (Scopus)

Abstract

Plasmid-mediated class C β-lactamases are reported from Enterobacteriaceae with increasing frequency. They likely originate from chromosomal AmpC of certain Gram-negative bacterial species and subsequently are mobilized onto transmissible plasmids. There are reports of unfavorable clinical outcomes in patients infected with these organisms and treated with broad-spectrum cephalosporins. However, unlike class A extended-spectrum β-lactamases (ESBLs), no screening and confirmatory tests have been uniformly established for strains that produce class C β-lactamases. Reduced susceptibility to cefoxitin is a sensitive but not specific indicator of class C β-lactamase production. Simple confirmatory tests including tests using boronic acid compounds as specific class C β-lactamase inhibitors have recently been developed. Their utilization will enable clinical microbiology laboratories to report those strains producing plasmid-mediated class C β-lactamases as being resistant to all broad-spectrum cephalosporins, thus allowing physicians to prescribe appropriate antimicrobial therapy.

Original languageEnglish
Pages (from-to)191-197
Number of pages7
JournalInternational Journal of Infectious Diseases
Volume11
Issue number3
DOIs
Publication statusPublished - 01-05-2007

Fingerprint

Plasmids
Cephalosporins
Boronic Acids
Cefoxitin
Enterobacteriaceae
Microbiology
Physicians
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{c4c502a49f0c4972b80ba586a4caffb5,
title = "Detection of plasmid-mediated class C β-lactamases",
abstract = "Plasmid-mediated class C β-lactamases are reported from Enterobacteriaceae with increasing frequency. They likely originate from chromosomal AmpC of certain Gram-negative bacterial species and subsequently are mobilized onto transmissible plasmids. There are reports of unfavorable clinical outcomes in patients infected with these organisms and treated with broad-spectrum cephalosporins. However, unlike class A extended-spectrum β-lactamases (ESBLs), no screening and confirmatory tests have been uniformly established for strains that produce class C β-lactamases. Reduced susceptibility to cefoxitin is a sensitive but not specific indicator of class C β-lactamase production. Simple confirmatory tests including tests using boronic acid compounds as specific class C β-lactamase inhibitors have recently been developed. Their utilization will enable clinical microbiology laboratories to report those strains producing plasmid-mediated class C β-lactamases as being resistant to all broad-spectrum cephalosporins, thus allowing physicians to prescribe appropriate antimicrobial therapy.",
author = "Yohei Doi and Paterson, {David L.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1016/j.ijid.2006.07.008",
language = "English",
volume = "11",
pages = "191--197",
journal = "International Journal of Infectious Diseases",
issn = "1201-9712",
publisher = "Elsevier",
number = "3",

}

Detection of plasmid-mediated class C β-lactamases. / Doi, Yohei; Paterson, David L.

In: International Journal of Infectious Diseases, Vol. 11, No. 3, 01.05.2007, p. 191-197.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Detection of plasmid-mediated class C β-lactamases

AU - Doi, Yohei

AU - Paterson, David L.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Plasmid-mediated class C β-lactamases are reported from Enterobacteriaceae with increasing frequency. They likely originate from chromosomal AmpC of certain Gram-negative bacterial species and subsequently are mobilized onto transmissible plasmids. There are reports of unfavorable clinical outcomes in patients infected with these organisms and treated with broad-spectrum cephalosporins. However, unlike class A extended-spectrum β-lactamases (ESBLs), no screening and confirmatory tests have been uniformly established for strains that produce class C β-lactamases. Reduced susceptibility to cefoxitin is a sensitive but not specific indicator of class C β-lactamase production. Simple confirmatory tests including tests using boronic acid compounds as specific class C β-lactamase inhibitors have recently been developed. Their utilization will enable clinical microbiology laboratories to report those strains producing plasmid-mediated class C β-lactamases as being resistant to all broad-spectrum cephalosporins, thus allowing physicians to prescribe appropriate antimicrobial therapy.

AB - Plasmid-mediated class C β-lactamases are reported from Enterobacteriaceae with increasing frequency. They likely originate from chromosomal AmpC of certain Gram-negative bacterial species and subsequently are mobilized onto transmissible plasmids. There are reports of unfavorable clinical outcomes in patients infected with these organisms and treated with broad-spectrum cephalosporins. However, unlike class A extended-spectrum β-lactamases (ESBLs), no screening and confirmatory tests have been uniformly established for strains that produce class C β-lactamases. Reduced susceptibility to cefoxitin is a sensitive but not specific indicator of class C β-lactamase production. Simple confirmatory tests including tests using boronic acid compounds as specific class C β-lactamase inhibitors have recently been developed. Their utilization will enable clinical microbiology laboratories to report those strains producing plasmid-mediated class C β-lactamases as being resistant to all broad-spectrum cephalosporins, thus allowing physicians to prescribe appropriate antimicrobial therapy.

UR - http://www.scopus.com/inward/record.url?scp=34247196603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247196603&partnerID=8YFLogxK

U2 - 10.1016/j.ijid.2006.07.008

DO - 10.1016/j.ijid.2006.07.008

M3 - Review article

C2 - 17339123

AN - SCOPUS:34247196603

VL - 11

SP - 191

EP - 197

JO - International Journal of Infectious Diseases

JF - International Journal of Infectious Diseases

SN - 1201-9712

IS - 3

ER -